Nat. Med.

ISSN	1546-170X
ISSN-L	1078-8956
IUID	6efc0b2991e74ad5aa035146edd2461e
Modified	2020-11-27T13:14:05.134Z
Created	2017-05-09T09:12:08.353Z

Year 2024

PubMed DOI Crossref

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

De Laere B, Crippa A, Discacciati A, ..., Grönberg H, Lindberg J

Nat. Med. 30 (11) 3291-3302 [2024-11-00; online 2024-08-20]

Bioinformatics Support and Infrastructure [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative] Clinical Genomics Stockholm [Service]

PubMed DOI Crossref

Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.

Bojmar L, Zambirinis CP, Hernandez JM, ..., Jarnagin WR, Lyden D

Nat. Med. 30 (8) 2170-2180 [2024-08-00; online 2024-06-28]

Clinical Genomics Linköping [Service]

Year 2022

PubMed DOI Crossref

Implementing precision medicine in a regionally organized healthcare system in Sweden.

Fioretos T, Wirta V, Cavelier L, ..., Edsjö A, Rosenquist R

Nat. Med. 28 (10) 1980-1982 [2022-10-00; online 2022-09-20]

Clinical Genomics Gothenburg [Collaborative] Clinical Genomics Linköping [Service] Clinical Genomics Stockholm [Collaborative] Clinical Genomics Umeå [Service] Clinical Genomics Uppsala [Collaborative]

Year 2021

PubMed DOI Crossref

Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.

Muus C, Luecken MD, Eraslan G, ..., NHLBI LungMap Consortium , Human Cell Atlas Lung Biological Network

Nat. Med. 27 (3) 546-559 [2021-03-00; online 2021-03-02]

NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

PubMed DOI Crossref

Immune determinants of COVID-19 disease presentation and severity.

Brodin P

Nat. Med. 27 (1) 28-33 [2021-01-00; online 2021-01-13]

Cellular Immunomonitoring [Collaborative]

Year 2020

PubMed DOI Crossref

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Bernard E, Nannya Y, Hasserjian RP, ..., Ogawa S, Papaemmanuil E

Nat. Med. 26 (10) 1549-1556 [2020-10-00; online 2020-08-03]

Clinical Genomics Uppsala [Service]

PubMed DOI Crossref

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.

Tamborero D, Dienstmann R, Rachid MH, ..., Rodon J, Lehtiö J

Nat. Med. 26 (7) 992-994 [2020-07-00; online 2020-07-08]

Bioinformatics Support for Computational Resources [Service] Clinical Genomics Stockholm [Collaborative] Global Proteomics and Proteogenomics [Technology development]

Year 2019

PubMed DOI Crossref

A clonal expression biomarker associates with lung cancer mortality.

Biswas D, Birkbak NJ, Rosenthal R, ..., Swanton C, TRACERx Consortium

Nat. Med. 25 (10) 1540-1548 [2019-10-00; online 2019-10-07]

Clinical Genomics Uppsala [Collaborative]

PubMed DOI Crossref

Gain-of-function mutation of microRNA-140 in human skeletal dysplasia.

Grigelioniene G, Suzuki HI, Taylan F, ..., Sharp PA, Kobayashi T

Nat. Med. 25 (4) 583-590 [2019-04-00; online 2019-02-25]

Clinical Genomics Stockholm [Service] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

Year 2018

PubMed DOI Crossref

CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.

Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J

Nat. Med. 24 (7) 927-930 [2018-07-00; online 2018-06-11]

CRISPR Functional Genomics [Collaborative] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service] Protein Science Facility (PSF) [Service]

PubMed DOI Crossref

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.

Roswall P, Bocci M, Bartoschek M, ..., Eriksson U, Pietras K

Nat. Med. 24 (4) 463-473 [2018-05-00; online 2018-03-12]

Clinical Genomics Lund [Service]

Year 2017

PubMed DOI Crossref

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.

Davies H, Glodzik D, Morganella S, ..., Stratton MR, Nik-Zainal S

Nat. Med. 23 (4) 517-525 [2017-04-00; online 2017-03-13]

Clinical Genomics Lund [Collaborative]

PubMed DOI Crossref

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.

Herold N, Rudd SG, Ljungblad L, ..., Helleday T, Schaller T

Nat. Med. 23 (2) 256-263 [2017-02-00; online 2017-01-09]

Chemical Biology Consortium Sweden (CBCS) [Collaborative] Protein Science Facility (PSF) [Service]

Year 2015

PubMed DOI Crossref

Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.

Vizoso M, Ferreira HJ, Lopez-Serra P, ..., Marais R, Esteller M

Nat. Med. 21 (7) 741-750 [2015-07-00; online 2015-06-01]

Tissue Profiling [Collaborative]

Year 2011

PubMed DOI Crossref

Inhibition of proteasome deubiquitinating activity as a new cancer therapy.

D'Arcy P, Brnjic S, Olofsson MH, ..., Larsson R, Linder S

Nat. Med. 17 (12) 1636-1640 [2011-11-06; online 2011-11-06]

Array and Analysis Facility